AR024847A1 - 4-alquenil y 4-alquinil oxindoles, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento. - Google Patents
4-alquenil y 4-alquinil oxindoles, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento.Info
- Publication number
- AR024847A1 AR024847A1 ARP990106414A ARP990106414A AR024847A1 AR 024847 A1 AR024847 A1 AR 024847A1 AR P990106414 A ARP990106414 A AR P990106414A AR P990106414 A ARP990106414 A AR P990106414A AR 024847 A1 AR024847 A1 AR 024847A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture
- pharmaceutical composition
- oxindols
- alquinil
- alquenil
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 108091007914 CDKs Proteins 0.000 abstract 2
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 2
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 102000015792 Cyclin-Dependent Kinase 2 Human genes 0.000 abstract 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 208000035269 cancer or benign tumor Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
4-alquenil y 4-alquinil oxindoles que presentan la formula 1 y 2 y las sales farmacéuticamente aceptable de los mismos en los que R1, R2, R3, a, b y X soncomo se define en la memoria descriptiva, inhiben las quinasas dependientes de ciclina (CDKs), en particular la CDK2, y son utiles como agentesantiproliferativos en el tratamiento o control de trastornos de la proliferacion celular, en particular tumores de colon o de mama. Composicion farmacéutica yel uso de los mismos para la fabricacion de un medicamento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11259198P | 1998-12-17 | 1998-12-17 | |
| US14907399P | 1999-08-16 | 1999-08-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR024847A1 true AR024847A1 (es) | 2002-10-30 |
Family
ID=26810131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990106414A AR024847A1 (es) | 1998-12-17 | 1999-12-15 | 4-alquenil y 4-alquinil oxindoles, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento. |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US6130239A (es) |
| EP (1) | EP1157019B1 (es) |
| JP (1) | JP2002532492A (es) |
| KR (1) | KR100649925B1 (es) |
| CN (1) | CN1138773C (es) |
| AR (1) | AR024847A1 (es) |
| AT (1) | ATE234830T1 (es) |
| AU (1) | AU770375B2 (es) |
| BR (1) | BR9916327A (es) |
| CA (1) | CA2354873A1 (es) |
| CO (1) | CO5261600A1 (es) |
| DE (1) | DE69906152T2 (es) |
| DK (1) | DK1157019T3 (es) |
| ES (1) | ES2192877T3 (es) |
| PE (1) | PE20001537A1 (es) |
| PT (1) | PT1157019E (es) |
| TR (1) | TR200101860T2 (es) |
| TW (1) | TW550262B (es) |
| UY (1) | UY25857A1 (es) |
| WO (1) | WO2000035908A1 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569868B2 (en) | 1998-04-16 | 2003-05-27 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| AU770375B2 (en) * | 1998-12-17 | 2004-02-19 | F. Hoffmann-La Roche Ag | 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular CDK2 |
| US6878733B1 (en) | 1999-11-24 | 2005-04-12 | Sugen, Inc. | Formulations for pharmaceutical agents ionizable as free acids or free bases |
| JP5336686B2 (ja) * | 1999-11-24 | 2013-11-06 | スージェン， インク． | 遊離酸または遊離塩基としてイオン化可能な医薬品のための処方 |
| EP1255536B1 (en) * | 1999-12-22 | 2006-06-28 | Sugen, Inc. | Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| MY130363A (en) * | 2000-02-15 | 2007-06-29 | Sugen Inc | "pyrrole substituted 2-indolinone protein kinase inhibitors" |
| EP1272483A2 (en) * | 2000-03-24 | 2003-01-08 | Millenium Pharmaceuticals, Inc. | OXINDOLE INHIBITORS OF FACTOR Xa |
| MY128450A (en) | 2000-05-24 | 2007-02-28 | Upjohn Co | 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| US6706709B2 (en) | 2000-06-02 | 2004-03-16 | Sugen, Inc. | Indolinone derivatives as protein kinase/phosphatase inhibitors |
| CA2414468A1 (en) * | 2000-06-30 | 2002-01-10 | Sugen, Inc. | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| CA2432114A1 (en) | 2000-12-20 | 2002-07-18 | Sugen, Inc. | 4-(hetero)aryl substituted indolinones |
| US6504034B2 (en) | 2001-01-23 | 2003-01-07 | Hoffmann-La Roche Inc. | Naphthostyrils |
| AR042586A1 (es) | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
| FR2822155B1 (fr) | 2001-03-13 | 2003-12-12 | Aventis Pharma Sa | Composes derives des oxindoles et leur application therapeutique en cancerologie |
| CA2455050C (en) * | 2001-08-15 | 2007-02-20 | Pharmacia & Upjohn Company | Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| MXPA04003385A (es) | 2001-10-10 | 2005-04-11 | Sugen Inc | Derivados de 3-?4-substituido con heterociclilo)-pirrol-2-ilmetilidene?-2-indolinona como inhibidores de cinasa. |
| RU2316554C2 (ru) * | 2001-12-27 | 2008-02-10 | Тереванс, Инк. | Производные индолина, используемые как ингибиторы протеинкиназы |
| TW200526224A (en) * | 2003-12-22 | 2005-08-16 | Alcon Inc | Short form c-Maf transcription factor antagonists for treatment of glaucoma |
| FR2948940B1 (fr) * | 2009-08-04 | 2011-07-22 | Servier Lab | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US20140205537A1 (en) * | 2011-06-24 | 2014-07-24 | Zenobia Therapeutics, Inc. | Lrrk2 inhibitors |
| CN106187904B (zh) * | 2015-05-25 | 2021-07-06 | 中国医学科学院药物研究所 | 含丙炔酰胺基的2-苯基咪唑类衍生物及其制法和药物组合物与用途 |
| US11512067B2 (en) | 2017-09-14 | 2022-11-29 | Daiichi Sankyo Company, Limited | Compound having cyclic structure |
| WO2022113003A1 (en) | 2020-11-27 | 2022-06-02 | Rhizen Pharmaceuticals Ag | Cdk inhibitors |
| WO2022149057A1 (en) | 2021-01-05 | 2022-07-14 | Rhizen Pharmaceuticals Ag | Cdk inhibitors |
| IL308314A (en) | 2021-05-07 | 2024-01-01 | Kymera Therapeutics Inc | CDK2 compounds and their uses |
| WO2026024674A1 (en) | 2024-07-22 | 2026-01-29 | Genesis Therapeutics, Inc. | Methods of treating skp2-associated cancers |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US5086186A (en) * | 1989-05-25 | 1992-02-04 | Pfizer Inc. | N-trichloroacetyl-2-oxindole-1-carboxamides |
| DK0429685T3 (da) * | 1989-07-25 | 1997-12-15 | Taiho Pharmaceutical Co Ltd | Oxoindolderivat |
| WO1991009598A1 (en) * | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Azaoxindole derivatives |
| GB9004483D0 (en) * | 1990-02-28 | 1990-04-25 | Erba Carlo Spa | New aryl-and heteroarylethenylene derivatives and process for their preparation |
| WO1992007830A2 (en) * | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
| GB9115160D0 (en) * | 1991-07-12 | 1991-08-28 | Erba Carlo Spa | Methylen-oxindole derivatives and process for their preparation |
| US5322950A (en) * | 1991-12-05 | 1994-06-21 | Warner-Lambert Company | Imidazole with angiotensin II antagonist properties |
| FR2694004B1 (fr) * | 1992-07-21 | 1994-08-26 | Adir | Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent. |
| GB9226855D0 (en) * | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
| GB9313638D0 (en) * | 1993-07-01 | 1993-08-18 | Erba Carlo Spa | Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
| GB9326136D0 (en) * | 1993-12-22 | 1994-02-23 | Erba Carlo Spa | Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
| GB9412719D0 (en) * | 1994-06-24 | 1994-08-17 | Erba Carlo Spa | Substituted azaindolylidene compounds and process for their preparation |
| GB9423997D0 (en) * | 1994-11-28 | 1995-01-11 | Erba Carlo Spa | Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| GB9501567D0 (en) * | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| GB9507298D0 (en) * | 1995-04-07 | 1995-05-31 | Pharmacia Spa | Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors |
| US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
| EP0850055B1 (en) * | 1995-09-11 | 2005-06-29 | Osteoarthritis Sciences, Inc. | Protein tyrosine kinase inhibitors for treating osteoarthritis |
| US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
| GB9610964D0 (en) * | 1996-05-24 | 1996-07-31 | Pharmacia & Upjohn Spa | Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| GB9611797D0 (en) * | 1996-06-06 | 1996-08-07 | Pharmacia Spa | Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| ATE308520T1 (de) * | 1996-08-23 | 2005-11-15 | Sugen Inc | Kombinatorische bibliotheken von indolinone und verwandte produkte und verfahren zur behandlung von krankheiten |
| WO1998024432A2 (en) * | 1996-12-05 | 1998-06-11 | Sugen, Inc. | Use of indolinone compounds as modulators of protein kinases |
| WO1998050356A1 (en) * | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| GB9716557D0 (en) * | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| AU3363599A (en) * | 1998-03-26 | 1999-10-18 | Max-Planck Institut Fur Biochemie | Heterocyclic families of compounds for the modulation of tyrosine protein kinase |
| EP1082305A4 (en) * | 1998-05-29 | 2001-09-26 | Sugen Inc | PYRROL SUBSTITUTED 2-INDOLINONE EFFECTIVE AS A PROTEIN KINASE INHIBITOR |
| JP2002522452A (ja) * | 1998-08-04 | 2002-07-23 | スージェン・インコーポレーテッド | 蛋白質キナーゼの調節剤３−メチリデニル−２−インドリノン |
| EP1117397A1 (en) * | 1998-08-31 | 2001-07-25 | Sugen, Inc. | Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| AU770375B2 (en) * | 1998-12-17 | 2004-02-19 | F. Hoffmann-La Roche Ag | 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular CDK2 |
-
1999
- 1999-12-08 AU AU19727/00A patent/AU770375B2/en not_active Ceased
- 1999-12-08 TR TR2001/01860T patent/TR200101860T2/xx unknown
- 1999-12-08 DK DK99963422T patent/DK1157019T3/da active
- 1999-12-08 CA CA002354873A patent/CA2354873A1/en not_active Abandoned
- 1999-12-08 ES ES99963422T patent/ES2192877T3/es not_active Expired - Lifetime
- 1999-12-08 BR BR9916327-6A patent/BR9916327A/pt not_active Application Discontinuation
- 1999-12-08 AT AT99963422T patent/ATE234830T1/de not_active IP Right Cessation
- 1999-12-08 WO PCT/EP1999/009624 patent/WO2000035908A1/en not_active Ceased
- 1999-12-08 JP JP2000588168A patent/JP2002532492A/ja active Pending
- 1999-12-08 CN CNB998145246A patent/CN1138773C/zh not_active Expired - Fee Related
- 1999-12-08 EP EP99963422A patent/EP1157019B1/en not_active Expired - Lifetime
- 1999-12-08 PT PT99963422T patent/PT1157019E/pt unknown
- 1999-12-08 DE DE69906152T patent/DE69906152T2/de not_active Expired - Fee Related
- 1999-12-08 KR KR1020017007610A patent/KR100649925B1/ko not_active Expired - Fee Related
- 1999-12-14 CO CO99078069A patent/CO5261600A1/es not_active Application Discontinuation
- 1999-12-14 PE PE1999001251A patent/PE20001537A1/es not_active Application Discontinuation
- 1999-12-15 AR ARP990106414A patent/AR024847A1/es not_active Application Discontinuation
- 1999-12-15 US US09/464,502 patent/US6130239A/en not_active Expired - Fee Related
- 1999-12-16 UY UY25857A patent/UY25857A1/es not_active Application Discontinuation
- 1999-12-16 TW TW088122068A patent/TW550262B/zh active
-
2000
- 2000-04-14 US US09/549,864 patent/US6252086B1/en not_active Expired - Fee Related
- 2000-05-05 US US09/566,054 patent/US6303793B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR9916327A (pt) | 2001-09-18 |
| TR200101860T2 (tr) | 2001-12-21 |
| TW550262B (en) | 2003-09-01 |
| UY25857A1 (es) | 2001-07-31 |
| DK1157019T3 (da) | 2003-07-14 |
| US6252086B1 (en) | 2001-06-26 |
| JP2002532492A (ja) | 2002-10-02 |
| KR20010101274A (ko) | 2001-11-14 |
| DE69906152T2 (de) | 2004-02-12 |
| ATE234830T1 (de) | 2003-04-15 |
| ES2192877T3 (es) | 2003-10-16 |
| KR100649925B1 (ko) | 2007-02-28 |
| PT1157019E (pt) | 2003-06-30 |
| WO2000035908A1 (en) | 2000-06-22 |
| CN1330647A (zh) | 2002-01-09 |
| EP1157019A1 (en) | 2001-11-28 |
| PE20001537A1 (es) | 2001-01-09 |
| US6303793B1 (en) | 2001-10-16 |
| US6130239A (en) | 2000-10-10 |
| CA2354873A1 (en) | 2000-06-22 |
| CO5261600A1 (es) | 2003-03-31 |
| AU770375B2 (en) | 2004-02-19 |
| EP1157019B1 (en) | 2003-03-19 |
| CN1138773C (zh) | 2004-02-18 |
| AU1972700A (en) | 2000-07-03 |
| DE69906152D1 (de) | 2003-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR024847A1 (es) | 4-alquenil y 4-alquinil oxindoles, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento. | |
| AR028810A1 (es) | Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion | |
| CY1108408T1 (el) | Παραγωγα διαζεπινοϊνδολιου ως αναστολεις κινασης | |
| AR066982A2 (es) | Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos | |
| PA8442001A1 (es) | Derivados de pirimidina biciclica condensada | |
| NO304793B1 (no) | nor-gallesyrederivater, og anvendelse av dem for fremstilling av legemiddel | |
| AR026036A1 (es) | Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos | |
| BRPI0412348A (pt) | derivados de piperazina e seu uso como agentes terapêuticos | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| AR025389A1 (es) | Indolinonas sustituidas, su preparacion y su empleo como medicamentos | |
| AR023542A1 (es) | Pirazolbenzodiazepinas | |
| AR029454A1 (es) | Derivados de piperazina sustituidos, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la elaboracion de medicamentos | |
| UY27592A1 (es) | Nuevo uso | |
| ES2153820T3 (es) | Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones. | |
| UY28736A1 (es) | Derivados de quinazolina | |
| AR027113A1 (es) | Piperidinas sustiutidas, medicamentos que contienen estos compuestos y procedimiento par su preparacion | |
| ATE236147T1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
| DE602004014163D1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
| DE60001586D1 (de) | Diphenyl-piperidin derivate | |
| AR043071A1 (es) | Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| TR200003122T2 (tr) | Aril bağlı azapolisiklik bileşikler | |
| AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
| ES2192878T3 (es) | 4,5-azolo-oxindoles. | |
| IS7562A (is) | Sýanógúanidínforlyf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |